Moors & Cabot, Inc. Merck & Co., Inc. Call Options Transaction History

Moors & Cabot, Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $124,967 - $140,080	-1,700 Reduced 68.0%	800 $4,000
Q3 2021 Dec 08, 2021	BUY	$71.68 - $78.83 $164,864 - $181,309	2,300 Added 1150.0%	2,500 $2,000
Q3 2020 Nov 09, 2020	SELL	$73.18 - $82.95 $2.55 Million - $2.89 Million	-34,800 Reduced 99.43%	200 $1,000
Q3 2019 Oct 22, 2019	BUY	$76.08 - $82.93 $2.66 Million - $2.9 Million	35,000 New	35,000 $29,000

3,768

1.87B

17.3M

14.8M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $319B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.